4DMedical Ltd's stock soared 39.74% intraday on Wednesday, reaching record highs.
The surge follows the company's announcement that its CT:VQ respiratory imaging technology has been deployed at the Mayo Clinic in the United States, a leading healthcare institution. This deployment is seen as a significant endorsement and is expected to accelerate broader commercial adoption of the technology.
The company's CEO described this as a "landmark moment," noting that CT:VQ has now been deployed at six top American medical centers within seven months of FDA clearance, building strong commercial momentum and strengthening the sales pipeline.